Global Biologics and Biosimilars Sales Market Report 2020
SKU ID : QYR-16678936 | Publishing Date : 27-Oct-2020 | No. of pages : 149
Detailed TOC of Global Biologics and Biosimilars Sales Market Report 2020
1 Biologics and Biosimilars Market Overview1.1 Biologics and Biosimilars Product Scope
1.2 Biologics and Biosimilars Segment by Type
1.2.1 Global Biologics and Biosimilars Sales by Type (2020-2026)
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Biologics and Biosimilars Segment by Application
1.3.1 Global Biologics and Biosimilars Sales Comparison by Application (2020-2026)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Biologics and Biosimilars Market Estimates and Forecasts (2015-2026)
1.4.1 Global Biologics and Biosimilars Sales Growth Rate (2015-2026)
1.4.2 Global Biologics and Biosimilars Revenue and Growth Rate (2015-2026)
1.4.3 Global Biologics and Biosimilars Price Trends (2015-2026)
2 Biologics and Biosimilars Estimate and Forecast by Region
2.1 Global Biologics and Biosimilars Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Biologics and Biosimilars Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Biologics and Biosimilars Sales Market Share by Region (2015-2020)
2.2.2 Global Biologics and Biosimilars Revenue Market Share by Region (2015-2020)
2.3 Global Biologics and Biosimilars Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Biologics and Biosimilars Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Biologics and Biosimilars Estimates and Projections (2015-2026)
2.4.2 Europe Biologics and Biosimilars Estimates and Projections (2015-2026)
2.4.3 China Biologics and Biosimilars Estimates and Projections (2015-2026)
2.4.4 Japan Biologics and Biosimilars Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Biologics and Biosimilars Estimates and Projections (2015-2026)
2.4.6 India Biologics and Biosimilars Estimates and Projections (2015-2026)
3 Global Biologics and Biosimilars Competition Landscape by Players
3.1 Global Top Biologics and Biosimilars Players by Sales (2015-2020)
3.2 Global Top Biologics and Biosimilars Players by Revenue (2015-2020)
3.3 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2019)
3.4 Global Biologics and Biosimilars Average Price by Company (2015-2020)
3.5 Manufacturers Biologics and Biosimilars Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Biologics and Biosimilars Players (Opinion Leaders)
4 Global Biologics and Biosimilars Market Size by Type
4.1 Global Biologics and Biosimilars Historic Market Review by Type (2015-2020)
4.1.1 Global Biologics and Biosimilars Sales Market Share by Type (2015-2020)
4.1.2 Global Biologics and Biosimilars Revenue Market Share by Type (2015-2020)
4.1.3 Global Biologics and Biosimilars Price by Type (2015-2020)
4.2 Global Biologics and Biosimilars Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Global Biologics and Biosimilars Price Forecast by Type (2021-2026)
5 Global Biologics and Biosimilars Market Size by Application
5.1 Global Biologics and Biosimilars Historic Market Review by Application (2015-2020)
5.1.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
5.1.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020)
5.1.3 Global Biologics and Biosimilars Price by Application (2015-2020)
5.2 Global Biologics and Biosimilars Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologics and Biosimilars Price Forecast by Application (2021-2026)
6 United States Biologics and Biosimilars Market Facts & Figures
6.1 United States Biologics and Biosimilars Sales Market Share by Company (2015-2020)
6.2 United States Biologics and Biosimilars Sales Market Share by Type (2015-2020)
6.3 United States Biologics and Biosimilars Sales Market Share by Application (2015-2020)
7 Europe Biologics and Biosimilars Market Facts & Figures
7.1 Europe Biologics and Biosimilars Sales Market Share by Company (2015-2020)
7.2 Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020)
7.3 Europe Biologics and Biosimilars Sales Market Share by Application (2015-2020)
8 China Biologics and Biosimilars Market Facts & Figures
8.1 China Biologics and Biosimilars Sales Market Share by Company (2015-2020)
8.2 China Biologics and Biosimilars Sales Market Share by Type (2015-2020)
8.3 China Biologics and Biosimilars Sales Market Share by Application (2015-2020)
9 Japan Biologics and Biosimilars Market Facts & Figures
9.1 Japan Biologics and Biosimilars Sales Market Share by Company (3015-3030)
9.2 Japan Biologics and Biosimilars Sales Market Share by Type (2015-2020)
9.3 Japan Biologics and Biosimilars Sales Market Share by Application (2015-2020)
10 Southeast Asia Biologics and Biosimilars Market Facts & Figures
10.1 Southeast Asia Biologics and Biosimilars Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2015-2020)
11 India Biologics and Biosimilars Market Facts & Figures
11.1 India Biologics and Biosimilars Sales Market Share by Company (2015-2020)
11.2 India Biologics and Biosimilars Sales Market Share by Type (2015-2020)
11.3 India Biologics and Biosimilars Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Biologics and Biosimilars Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Biologics and Biosimilars Products Offered
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Business Overview
12.2.3 Amgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Biologics and Biosimilars Products Offered
12.2.5 Amgen Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Business Overview
12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Biologics and Biosimilars Products Offered
12.3.5 AbbVie Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Corporation Information
12.4.2 Sanofi-Aventis Business Overview
12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi-Aventis Biologics and Biosimilars Products Offered
12.4.5 Sanofi-Aventis Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Business Overview
12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Biologics and Biosimilars Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Biologics and Biosimilars Products Offered
12.6.5 Pfizer Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Corporation Information
12.7.2 Novo Nordisk Business Overview
12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novo Nordisk Biologics and Biosimilars Products Offered
12.7.5 Novo Nordisk Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Biologics and Biosimilars Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Business Overview
12.9.3 Novartis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis Biologics and Biosimilars Products Offered
12.9.5 Novartis Recent Development
12.10 Merck
12.10.1 Merck Corporation Information
12.10.2 Merck Business Overview
12.10.3 Merck Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck Biologics and Biosimilars Products Offered
12.10.5 Merck Recent Development
12.11 3sbio
12.11.1 3sbio Corporation Information
12.11.2 3sbio Business Overview
12.11.3 3sbio Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.11.4 3sbio Biologics and Biosimilars Products Offered
12.11.5 3sbio Recent Development
12.12 Changchun High Tech
12.12.1 Changchun High Tech Corporation Information
12.12.2 Changchun High Tech Business Overview
12.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Changchun High Tech Biologics and Biosimilars Products Offered
12.12.5 Changchun High Tech Recent Development
12.13 CP Guojian
12.13.1 CP Guojian Corporation Information
12.13.2 CP Guojian Business Overview
12.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.13.4 CP Guojian Biologics and Biosimilars Products Offered
12.13.5 CP Guojian Recent Development
12.14 Biotech
12.14.1 Biotech Corporation Information
12.14.2 Biotech Business Overview
12.14.3 Biotech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Biotech Biologics and Biosimilars Products Offered
12.14.5 Biotech Recent Development
12.15 Gelgen
12.15.1 Gelgen Corporation Information
12.15.2 Gelgen Business Overview
12.15.3 Gelgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Gelgen Biologics and Biosimilars Products Offered
12.15.5 Gelgen Recent Development
12.16 Innovent
12.16.1 Innovent Corporation Information
12.16.2 Innovent Business Overview
12.16.3 Innovent Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Innovent Biologics and Biosimilars Products Offered
12.16.5 Innovent Recent Development
12.17 Dong Bao
12.17.1 Dong Bao Corporation Information
12.17.2 Dong Bao Business Overview
12.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Dong Bao Biologics and Biosimilars Products Offered
12.17.5 Dong Bao Recent Development
12.18 Ganlee
12.18.1 Ganlee Corporation Information
12.18.2 Ganlee Business Overview
12.18.3 Ganlee Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Ganlee Biologics and Biosimilars Products Offered
12.18.5 Ganlee Recent Development
13 Biologics and Biosimilars Manufacturing Cost Analysis
13.1 Biologics and Biosimilars Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biologics and Biosimilars
13.4 Biologics and Biosimilars Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biologics and Biosimilars Distributors List
14.3 Biologics and Biosimilars Customers
15 Market Dynamics
15.1 Biologics and Biosimilars Market Trends
15.2 Biologics and Biosimilars Opportunities and Drivers
15.3 Biologics and Biosimilars Market Challenges
15.4 Biologics and Biosimilars Market Restraints
15.5 Porter's Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Figures, Tables and Charts Available in Global Biologics and Biosimilars Sales Market Report 2020
List of TablesTable 1. Global Biologics and Biosimilars Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Biologics and Biosimilars Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Biologics and Biosimilars Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Biologics and Biosimilars Sales (K Units) by Region (2015-2020)
Table 5. Global Biologics and Biosimilars Sales Market Share by Region (2015-2020)
Table 6. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Biologics and Biosimilars Revenue Share by Region (2015-2020)
Table 8. Global Biologics and Biosimilars Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Biologics and Biosimilars Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Biologics and Biosimilars Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Biologics and Biosimilars Revenue Share Forecast by Region (2021-2026)
Table 12. Global Biologics and Biosimilars (K Units) of Key Companies (2015-2020)
Table 13. Global Biologics and Biosimilars Sales Share by Company (2015-2020)
Table 14. Global Biologics and Biosimilars Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Biologics and Biosimilars Revenue Share by Company (2015-2020)
Table 16. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2019)
Table 17. Global Biologics and Biosimilars Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Biologics and Biosimilars Manufacturing Sites and Area Served
Table 19. Manufacturers Biologics and Biosimilars Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Biologics and Biosimilars Players
Table 22. Global Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 23. Global Biologics and Biosimilars Sales Share by Type (2015-2020)
Table 24. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Biologics and Biosimilars Price (K Units) by Type (2015-2020)
Table 26. Global Biologics and Biosimilars Sales Share by Type (2021-2026)
Table 27. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Biologics and Biosimilars Revenue Share by Type (2021-2026)
Table 29. Global Biologics and Biosimilars Price (K Units) by Type (2021-2026)
Table 30. Global Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 31. Global Biologics and Biosimilars Sales Share by Application (2015-2020)
Table 32. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Biologics and Biosimilars Price (K Units) by Application (2015-2020)
Table 34. Global Biologics and Biosimilars Sales (K Units) by Application (2021-2026)
Table 35. Global Biologics and Biosimilars Sales Share by Application (2021-2026)
Table 36. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Biologics and Biosimilars Revenue Share by Application (2021-2026)
Table 38. Global Biologics and Biosimilars Price (K Units) by Application (2021-2026)
Table 39. United States Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 40. United States Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 41. United States Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 42. United States Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 43. United States Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 44. United States Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 45. Europe Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 46. Europe Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 47. Europe Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 48. Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 49. Europe Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 50. Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 51. China Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 52. China Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 53. China Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 54. China Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 55. China Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 56. China Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 57. Japan Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 58. Japan Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 59. Japan Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 60. Japan Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 61. Japan Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 62. Japan Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 69. India Biologics and Biosimilars Sales (K Units) by Company (2015-2020)
Table 70. India Biologics and Biosimilars Sales Market Share by Company (2015-2020)
Table 71. India Biologics and Biosimilars Sales (K Units) by Type (2015-2020)
Table 72. India Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Table 73. India Biologics and Biosimilars Sales (K Units) by Application (2015-2020)
Table 74. India Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Roche Biologics and Biosimilars Product
Table 79. Roche Recent Development
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Amgen Biologics and Biosimilars Product
Table 84. Amgen Recent Development
Table 85. AbbVie Corporation Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AbbVie Biologics and Biosimilars Product
Table 89. AbbVie Recent Development
Table 90. Sanofi-Aventis Corporation Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi-Aventis Biologics and Biosimilars Product
Table 94. Sanofi-Aventis Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Biologics and Biosimilars Product
Table 99. Johnson & Johnson Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pfizer Biologics and Biosimilars Product
Table 104. Pfizer Recent Development
Table 105. Novo Nordisk Corporation Information
Table 106. Novo Nordisk Description and Business Overview
Table 107. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novo Nordisk Biologics and Biosimilars Product
Table 109. Novo Nordisk Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Eli Lilly Description and Business Overview
Table 113. Eli Lilly Biologics and Biosimilars Product
Table 114. Eli Lilly Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Biologics and Biosimilars Product
Table 119. Novartis Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Merck Biologics and Biosimilars Product
Table 124. Merck Recent Development
Table 125. 3sbio Corporation Information
Table 126. 3sbio Description and Business Overview
Table 127. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. 3sbio Biologics and Biosimilars Product
Table 129. 3sbio Recent Development
Table 130. Changchun High Tech Corporation Information
Table 131. Changchun High Tech Description and Business Overview
Table 132. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Changchun High Tech Biologics and Biosimilars Product
Table 134. Changchun High Tech Recent Development
Table 135. CP Guojian Corporation Information
Table 136. CP Guojian Description and Business Overview
Table 137. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. CP Guojian Biologics and Biosimilars Product
Table 139. CP Guojian Recent Development
Table 140. Biotech Corporation Information
Table 141. Biotech Description and Business Overview
Table 142. Biotech Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Biotech Biologics and Biosimilars Product
Table 144. Biotech Recent Development
Table 145. Gelgen Corporation Information
Table 146. Gelgen Description and Business Overview
Table 147. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Gelgen Biologics and Biosimilars Product
Table 149. Gelgen Recent Development
Table 150. Innovent Corporation Information
Table 151. Innovent Description and Business Overview
Table 152. Innovent Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Innovent Biologics and Biosimilars Product
Table 154. Innovent Recent Development
Table 155. Dong Bao Corporation Information
Table 156. Dong Bao Description and Business Overview
Table 157. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Dong Bao Biologics and Biosimilars Product
Table 159. Dong Bao Recent Development
Table 160. Ganlee Corporation Information
Table 161. Ganlee Description and Business Overview
Table 162. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Ganlee Biologics and Biosimilars Product
Table 164. Ganlee Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Biologics and Biosimilars Distributors List
Table 168. Biologics and Biosimilars Customers List
Table 169. Biologics and Biosimilars Market Key Trends
Table 170. Biologics and Biosimilars Key Opportunities and Drivers
Table 171. Biologics and Biosimilars Market Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics and Biosimilars Product Picture
Figure 2. Global Biologics and Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Biologics and Biosimilars Market Share by Application in 2020 & 2026
Figure 6. Tumor Examples
Figure 7. Diabetes Examples
Figure 8. Cardiovascular Examples
Figure 9. Hemophilia Examples
Figure 10. Others Examples
Figure 11. Global Biologics and Biosimilars Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Biologics and Biosimilars Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Biologics and Biosimilars Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Biologics and Biosimilars Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Biologics and Biosimilars Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Biologics and Biosimilars Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Biologics and Biosimilars Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Biologics and Biosimilars Players Market Share by Revenue in Biologics and Biosimilars 2015 & 2019
Figure 29. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Biologics and Biosimilars Revenue Share by Type (2015-2020)
Figure 31. Global Biologics and Biosimilars Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Biologics and Biosimilars Revenue Share by Application (2015-2020)
Figure 33. Global Biologics and Biosimilars Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 35. United States Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 36. Europe Biologics and Biosimilars Sales Market Share by Company in 2019
Figure 37. Europe Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 38. Europe Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 39. China Biologics and Biosimilars Sales Market Share by Company in 2019
Figure 40. China Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 41. China Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 42. Japan Biologics and Biosimilars Sales Market Share by Company in 2019
Figure 43. Japan Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 44. Japan Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 45. Southeast Asia Biologics and Biosimilars Sales Market Share by Company in 2019
Figure 46. Southeast Asia Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 47. Southeast Asia Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 48. India Biologics and Biosimilars Sales Market Share by Company in 2019
Figure 49. India Biologics and Biosimilars Sales Market Share by Type in 2019
Figure 50. India Biologics and Biosimilars Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Biologics and Biosimilars
Figure 53. Manufacturing Process Analysis of Biologics and Biosimilars
Figure 54. Biologics and Biosimilars Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Keyplayers in Global Biologics and Biosimilars Sales Market Report 2020
RocheAmgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee